Indian deep-tech startup Prantae Solutions, from Bhubaneswar has today announced that it has attracted a seed funding of ₹5 crore. Life Science Angels Network (IAN) Group led the investment with participation from IAN Alpha Fund and some of the notable angel investors including Samir Kalia, Deepank Kumar and Nitin Zamre.
Pioneering Diagnostic Innovations
Prantae Solutions is a next generation diagnostic tools company working toward amelioration of key healthcare problems founded by visionary entrepreneurs Sumona Karjee Mishra and Aseem Mishra in 2015.
Fresh investments will let the company launch advanced diagnostic tools, with a strong emphasis on kidney health and diabetes care very soon.
Meet Proflo-U: Revolutionary Kidney Assessment Tool
The essence of Prantae Innovation, their flagship product Proflo-U at the heart of both boutique dialysis tech and the startup’s flagship innovation problemset of innovation.
A method to disrupt kidney health assessment, invented on-cutting-edge diagnostic tool The nanosensor technology (approved by MIIT/FDA) embedded in Proflo-U works seamlessly with IoT & Artificial Intelligence in a calibration-free model offering a cost-effective, user-friendly testing solution.
Its super-range of detection from microalbumin to proteinuria means that disease can be detected early and chronic kidney disease managed before traditional markers of CKD intervene, resulting in superior patient care and cost reductions for healthcare.
Strategic Vision and Market Expansion
Practea Solutions is deeply committed to the company’s vision of intellectual property and innovation at home before opening overseas fronts, given that it stands on an extensive IP with focus on healthcare products.
Garaging, over 17 years now; we are seeking to bridge the access and quality divide worldwide with our truly distinctive point-of-care (POC) diagnostic products.
Emerging Point-of-Care Diagnostics Market
India point-of-care diagnostics market is large and growing quickly The prospective value of$1.41 Billion at present FY2024 is expected to surge to$2.71 billion by FY2032 with compound annual growth rate (CAGR) of8.47%. This upward trajectory highlights the enormous capacity for innovation in this space and it is Prantae Solutions’ ambition to deliver top-notch diagnostic tools.
Leadership Perspectives
In an excited voice Sumona Karjee Mishra, The Chairman & Managing Director of Prantae Solutions, stated “Indian Angel Network has been very instrumental in giving us wings to fly through the healthcare transformation journey. This capital mission is behind our shared vision for the world with excellent point-of-care diagnostics (PocD), enabled by our core product Proflo-U to advance early detection and personalized kidney care. We are together shaping a future of innovation meets compassion that redefine health outcomes for people everywhere.
Co-founder of IAN Group Padmaja Ruparel said, “Prantae Solutions is an outstanding illustration of bringing deep-tech innovation to solve key healthcare challenges especially in the under-served markets.”
Their breakthrough diagnostic innovations have the power to be more inclusive and accessible to healthcare, in India as well as globally as health.
Conclusion of Prantae Solutions
Prantae Solutions announced another funding milestone in its definitive Medical Diagnostics journey. Using cutting edge technologies and a patient first mindset will change the game for kidney and diabetes health assessment & management towards a better tomorrow.